QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

22,293 signal articles · 396 in last 24h · 107,278 total before filter · latest 1h ago
396last 24h
2492last 7d
494● bullish (7d)
238● bearish (7d)
200publishers
AllMacro213Earnings1534M&A124Regulatory16Product9Analyst25
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Pfizer raises revenue outlook after quarterly earnings top estimates
Proactive3d agoneutral
Pfizer raises revenue outlook after quarterly earnings top estimates

Pfizer Inc (NYSE:PFE, XETRA:PFE) beat Wall Street expectations for its second-quarter 2026 results and raised the midpoint of its full-year revenue guidance, as growth from launched and acquired products helped offset declines in its COVID-19 portfolio. The pharmaceutical company reported...

Aptiv Shares Decline as Weak Guidance Overshadows Second-Quarter Earnings Beat
InvestorsHub3d agobullish
Aptiv Shares Decline as Weak Guidance Overshadows Second-Quarter Earnings Beat

Aptiv PLC (NYSE:APTV) reported second-quarter 2026 results that exceeded Wall Street earnings expectations, but its shares fell nearly 4% in pre-market trading after the company issued weaker-than-expected guidance for both the third quarter and the full year. While quarterly performance was solid, investors focused on the softer outlook.

ASML (ENXTAM:ASML) Just Raised Its Interim Dividend 17% And Backed 2026 Guidance
Simply Wall St.3d agoneutral
ASML (ENXTAM:ASML) Just Raised Its Interim Dividend 17% And Backed 2026 Guidance

ASML Holding raised its interim dividend by 17% year over year, signaling confidence in its cash generation. The company paired the dividend move with strong 2026 revenue guidance, despite ongoing China related risks. The new payout level points to a strengthening income profile for shareholders alongside ASML’s leadership in chipmaking tools. ASML Holding, ticker ENXTAM:ASML, is reinforcing its income story with a higher interim dividend and firmer guidance. The stock trades at €1,419.6,...

Did Strong Q2 Earnings and an Analyst Upgrade Just Shift Generac Holdings' (GNRC) Investment Narrative?
Simply Wall St.3d agobullish
Did Strong Q2 Earnings and an Analyst Upgrade Just Shift Generac Holdings' (GNRC) Investment Narrative?

In late July 2026, Generac Holdings Inc. reported second-quarter 2026 results showing sales of US$1,173.51 million and net income of US$143.24 million, with both basic and diluted earnings per share from continuing operations rising compared with the same period a year earlier, and it also maintained its full-year 2026 net sales growth guidance in the mid-to-high teens percent range. Alongside these results, a subsequent upgrade to a top-tier analyst rating, driven by higher earnings...

BioNTech Q2 Earnings Call Highlights
MarketBeat3d agoneutral
BioNTech Q2 Earnings Call Highlights

BioNTech (NASDAQ:BNTX) reported second-quarter 2026 revenue of €106 million, down from €261 million a year earlier, as lower U.S. demand for its COVID-19 vaccine weighed on results. The prior-year quarter also benefited from a one-time compensation payment from Pfizer related to its decision to opt